As of 2025-07-04, the EV/EBITDA ratio of Jounce Therapeutics Inc (JNCE) is 1.06. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. JNCE's latest enterprise value is -51.62 mil USD. JNCE's TTM EBITDA according to its financial statements is -48.70 mil USD. Dividing these 2 quantities gives us the above JNCE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.1x - 9.9x | 8.7x |
| Forward P/E multiples | 11.5x - 13.8x | 12.0x |
| Fair Price | (7.80) - (6.32) | (6.71) |
| Upside | -514.8% - -436.0% | -457.2% |
| Date | EV/EBITDA |